Established in 2011, Teligene is a drug discovery company located in Suzhou BioBay, dedicating to developing innovative small-molecule drugs. The company has an experienced and lean management team leading highly skilled staffs of professionals with international experience and a broad range of expertise in R, combining the flexibility of a biotech with the quality standards of a big pharma.
It is committed to pursuing innovative therapeutic approaches in Oncology, discovering and developing molecules with novel mechanisms of action to improve patient outcomes in conditions with significant unmet medical need.
The company’s current project portfolio consists of a balanced oncology pipeline that spans from discovery to early stage clinical projects, with intellectual-property rights and potential advantages over existing therapeutics.
Investors 1
| Date | Name | Website |
| - | Loyal Vall... | loyalvalle... |